Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Nov;67(3):337-43.
doi: 10.1111/j.1476-5381.1979.tb08685.x.

Evidence for dopaminergic vasodilator innervation of the canine paw pad

Evidence for dopaminergic vasodilator innervation of the canine paw pad

C Bell et al. Br J Pharmacol. 1979 Nov.

Abstract

1 In chloralose-anaesthetized dogs pretreated with guanethidine and pancuronium, electrical stimulation (0.2 to 5 Hz) of the peripheral end of the cut tibial nerve caused a frequency-dependent increase in femoral blood flow which was restricted to the paw pads. 2 This neurogenic vasodilatation was not attenuated by atropine, mepyramine plus burimamide, indomethacin or propranolol. It was, however, attenuated in a dose-dependent manner by intra-arterial administration of the dopamine receptor antagonist, ergometrine (0.05 to 0.5 mg). 3 The effect of ergometrine could not be explained by non-specific effects on axonal conduction or transmission or by vasospasm of the blood vessels of the paw-pads. 4 In dogs with intact tibial nerves, a pharmacologically similar dilator response localized to the paw-pads could be elicited by electrical stimulation of loci in the ipsilateral diencephalon and midbrain. This response was not due to inhibition of adrenergic vasomotor tone and was abolished by systemic ganglion blockade or by tibial nerve section as well as by femoral arterial administration of ergometrine. 5 It is suggested that the vasculature of the canine paw pads is innervated by a population of autonomic axons which utilize dopamine or a related substance as a transmitter substance and activation of which causes vasodilation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pharmacol Biochem Behav. 1975 Mar-Apr;3(2):219-28 - PubMed
    1. Br J Pharmacol. 1975 Oct;55(2):167-72 - PubMed
    1. Acta Physiol Scand. 1952;27(1):18-37 - PubMed
    1. Br Med Bull. 1957 Sep;13(3):189-96 - PubMed
    1. Br J Pharmacol Chemother. 1961 Dec;17:442-50 - PubMed

LinkOut - more resources